In This Article:
The United Kingdom's stock market has been facing headwinds, with the FTSE 100 index closing lower due to weak trade data from China and a faltering global economy. Despite these challenges, value investing remains a viable strategy for discerning investors seeking opportunities in undervalued stocks.
Top 10 Undervalued Stocks Based On Cash Flows In The United Kingdom
Name | Current Price | Fair Value (Est) | Discount (Est) |
Gaming Realms (AIM:GMR) | £0.401 | £0.76 | 47.2% |
GlobalData (AIM:DATA) | £2.06 | £3.72 | 44.6% |
Tracsis (AIM:TRCS) | £5.50 | £10.01 | 45% |
Ferrexpo (LSE:FXPO) | £0.479 | £0.94 | 49.3% |
Informa (LSE:INF) | £8.398 | £16.23 | 48.3% |
Redcentric (AIM:RCN) | £1.2975 | £2.43 | 46.7% |
SysGroup (AIM:SYS) | £0.34 | £0.65 | 47.9% |
Foxtons Group (LSE:FOXT) | £0.622 | £1.18 | 47.3% |
Hochschild Mining (LSE:HOC) | £1.872 | £3.50 | 46.5% |
BATM Advanced Communications (LSE:BVC) | £0.20 | £0.36 | 44.9% |
Let's explore several standout options from the results in the screener.
ConvaTec Group
Overview: ConvaTec Group PLC develops, manufactures, and sells medical products, services, and technologies across Europe, North America, and internationally with a market cap of £4.71 billion.
Operations: The company's revenue from the development, manufacture, and sale of medical products and technologies amounts to $2.20 billion.
Estimated Discount To Fair Value: 39.5%
ConvaTec Group appears undervalued based on its discounted cash flow (DCF) analysis, trading at £2.3 against an estimated fair value of £3.8. The company recently reported a significant increase in net income to US$78.6 million for H1 2024, up from US$55.7 million a year ago, alongside earnings per share growth from US$0.027 to US$0.038. Despite high debt levels, ConvaTec's earnings are forecasted to grow annually by 21%, outpacing the UK market average of 14.4%.
-
Our growth report here indicates ConvaTec Group may be poised for an improving outlook.
-
Click here to discover the nuances of ConvaTec Group with our detailed financial health report.
Sage Group
Overview: The Sage Group plc, with a market cap of £10.34 billion, provides technology solutions and services for small and medium businesses in the United States, the United Kingdom, France, and internationally.
Operations: The company's revenue segments include £595 million from Europe, £1.01 billion from North America, and £488 million from the United Kingdom & Ireland.
Estimated Discount To Fair Value: 21.1%
Sage Group is trading at £10.37, significantly below its estimated fair value of £13.14, indicating it may be undervalued based on discounted cash flow analysis. The company reported a 9% revenue increase to £585 million for Q3 2024, driven by growth in the Sage Business Cloud portfolio. Despite high debt levels and insider selling, earnings are forecast to grow at 15.1% annually, outpacing the UK market's average growth rate of 14.4%.